Peter Kerr - Concepedia

Author

Peter Kerr

Institute of Cancer Research

Also Known As

P Kerr, P. Kerr, P.D. Kerr, Peter Kerr

Publications

859

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research University College London Breast Cancer Now Almac (United Kingdom)

About

Peter Kerr is an author at Institute of Cancer Research specializing in medicine, cell biology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	343
2	Cell Biology	3	3	304
3	Allergy	1	1	39
4	Cellular Physiology	1	1	73
5	Molecular Genetics	1	1	201

Peter Kerr

Publications

709

Citations

H-Index

Page 1

	Year	Citations
p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene Carmen Arias‐Lopez, Iciar Lazaro‐Trueba, Peter Kerr, EMBO Reports Genome InstabilityTranscriptional RegulationCell RegulationGeneticsRad51 Gene	2005	201
Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue Richard D. Kennedy, Max Bylesjö, Peter Kerr, Journal of Clinical Oncology	2011	187
Identification and Validation of an Anthracycline/Cyclophosphamide–Based Chemotherapy Response Assay in Breast Cancer Jude M. Mulligan, Laura A. Hill, Steve Deharo, JNCI Journal of the National Cancer Institute	2014	122
An Intrinsic Timer That Controls Cell-Cycle Withdrawal in Cultured Cardiac Myocytes Paul Burton, Martin Raff, Peter Kerr, Developmental Biology Cardiac MuscleCardiomyopathyHeart FailureMolecular PhysiologyControls Cell-cycle Withdrawal	1999	73
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance) Donna Niedzwiecki, Wendy L. Frankel, Alan P. Venook, Journal of Clinical Oncology	2016	57
VELOUR trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity Pratyaksha Wirapati, Valentina Pomella, Ben Vandenbosch, Annals of Oncology Biomarker (Medicine)Velour Trial BiomarkersAllergyMedicineBiomarker Target	2017	39
Cell cycle and genetic background dependence of the effect of loss of BRCA2 on ionizing radiation sensitivity Andrew Tutt, Frances Connor, David Bertwistle, Oncogene Radiation OncologyRadiation MedicineGeneticsGenetic Background DependenceRadiation Exposure	2003	30

Page 1